🇮🇳IN
Sign In
FR

FREDUN

NSE

Fredun Pharmaceuticals Ltd

₹1,488.20

-14.80(-0.98%)

Value & Investment Index

VII

VII Detail

90 days · zone the stock traded in

Multiples vs Peers

Quality Scores

Versus Its Own History

P/E · P/B percentile bands

Scenario analysis

stated assumptions, shown workings

FREDUN valuation summary

Fredun Pharmaceuticals Ltd trades at 53.5 times trailing earnings. Return on equity is 15.8% and return on capital employed is 21.5%. The dividend yield is 0.02%. That P/E equals an earnings yield of 1.9%. The median P/E across 102 listed Drug Manufacturers - Specialty & Generic companies is 35.6, so Fredun Pharmaceuticals Ltd trades at a 30% premium to that median.

P/E53.5
ROE15.8%
ROCE21.5%
Dividend yield0.02%

Investment in securities market are subject to market risks. Read all the related documents carefully before investing. Disclaimer